Chanukuppa, V. and Paul, D. and Taunk, K. and Chatterjee, T. and Sharma, S. and Kumar, S. and Santra, M.K. and Rapole, S. (2019) XPO1 is a critical player for bortezomib resistance in multiplemyeloma: A quantitative proteomic approach. Journal of Proteomics, 209. p. 103504.

Chanukuppa, V. and More, T.H. and Taunk, K. and Taware, R. and Chatterjee, T. and Sharmad, S. and Rapole, S. (2019) Serum metabolomic alterations in multiple myeloma revealed by targeted and untargeted metabolomics approaches: a pilot study. RSC Advances, 9 (51).

Chanukuppa, V. and Taware, R. and Chatterjee, T. and Sharma, S. and More, T.H. and Taunk, K. and Kumar, S. and Santra, M.K. and Rapole, S. (2018) Current understanding of the potential of proteomics andmetabolomics approaches in cancer chemoresistance: A focus on Multiple Myeloma. Current Topics in Medicinal Chemistry., 18 (30). pp. 2584-2598.

More, T.H. and Taware, R. and Taunk, K. and Chanukuppa, V. and Naik, V. and Mane, A. and Rapole, S. (2018) Investigation of altered urinary metabolomic profiles of invasive ductalcarcinoma of breast using targeted and untargeted approaches. Metabolomics, 14 (8). p. 107.

Paul , D. and Chanukuppa , V. and Reddy, P.J. and Taunk , K. and Adhav , R. and Srivastava , S. and Santra , M.K. and Rapole , S. (2016) Global proteomic profiling identifies etoposide chemoresistance markers in non-small cell lung carcinoma. Journal of Proteomics (138). pp. 95-105.